Serogroup Meningococcal Meningitis

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2018-10-10
Clinical Trial Update: Conjugate Vaccine Against Meningococcus C a Brazilian Project [Phase 2, Phase 3]
A Brazilian trial update for a conjugate vaccine targeting Serogroup C meningococcal meningitis in Phase 2/Phase 3 stages.